Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | SVP, Anc Srvcs & Srvc Strategy | May 31, 2024 | June 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date May 31, 2024 · Filed June 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,346.8559 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Tax withholding · Disposed 760 · Balance 9,346.8559 F1: On 5/31/2024, 2,016 shares of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 760 shares to pay tax obligations. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $63.96 · Expires 2027-02-18 | Direct | 3,734 |
Reported balance
Holding disclosure · report date 2024-05-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 3,734 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $53.94 · Expires 2028-03-08 | Direct | 7,467 |
Reported balance
Holding disclosure · report date 2024-05-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,467 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $94.10 · Expires 2029-03-05 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2024-05-31 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 12,000 |
Filing footnotes · ownership attribution and instrument terms
F1: On 5/31/2024, 2,016 shares of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 760 shares to pay tax obligations.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2024 Filed Jun 3, 2024 21:06 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 760 | $105.75 | $80,370.00 |
DisclosureSEC source: 0001437749-24-019073 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,346.8559 F1 · shares: On 5/31/2024, 2,016 shares of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 760 shares to pay tax obligations. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-24-007883 · rdgdoc.xml · derivative · entry 4 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,467 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 2,620 | $96.48 | $252,777.60 |
DisclosureSEC source: 0001437749-24-007883 · rdgdoc.xml · nonDerivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,106.8559 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 3,733 | $53.94 | $201,358.02 |
DisclosureSEC source: 0001437749-24-007883 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,726.8559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-24-006990 · rdgdoc.xml · derivative · entry 4 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-03-05 F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 5, 2025; one-third (1/3) will vest on March 5, 2026; and the final one-third (1/3) will vest on March 5, 2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006990 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,993.8559 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2025, the next 33 1/3% vesting on 1/1/2026, and the final 33 1/3% vesting on 1/1/2027. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-24-005590 · rdgdoc.xml · derivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,734 Underlying: Common Stock · 7,467 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 2,811 | $100.76 | $283,236.36 |
DisclosureSEC source: 0001437749-24-005590 · rdgdoc.xml · nonDerivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,920.8559 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 3,733 | $63.96 | $238,762.68 |
DisclosureSEC source: 0001437749-24-005590 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,731.8559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 02:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 342 | $92.42 | $31,607.64 |
DisclosureSEC source: 0001437749-24-000503 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,821.3938 F1 · shares: On 1/1/2024, 33 1/3 (or 909 shares) of restricted stock originally granted on 2/24/2021, 2/25/2022, and 3/8/2023 vested. The Company withheld 342 shares to pay tax obligations. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-23-032912 · rdgdoc.xml · derivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,467 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 3,296 | $77.33 | $254,879.68 |
DisclosureSEC source: 0001437749-23-032912 · rdgdoc.xml · nonDerivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,163.3938 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 21:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 3,733 | $63.96 | $238,762.68 |
DisclosureSEC source: 0001437749-23-032912 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,459.3938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common STock · Derivative | 11,200 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006033 · rdgdoc.xml · derivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 619 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006033 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726.3938 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:13 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 1,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004921 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,601.779 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004192 · rdgdoc.xml · derivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 22:33 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name or my spouse's name | 173 | $67.94 | $11,753.62 |
DisclosureSEC source: 0001437749-22-000199 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,003 F1 · shares: On 1/1/2022, 33 1/3 (or 584 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 173 shares to pay tax obligations. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 16,000 | $0.00 Strike: $60.73 | $0.00 |
DisclosureSEC source: 0001437749-21-006361 · rdgdoc.xml · derivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 11, 2021, the Compensation Committee amended the option to grant the ability to exercise up to 100% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original vest date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 11, 2021, the Compensation Committee amended the option to grant the ability to exercise up to 100% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original vest date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name or my spouse's name | 13,109 | $78.99 | $1,035,479.91 |
DisclosureSEC source: 0001437749-21-006361 · rdgdoc.xml · nonDerivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,176 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 21:50 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name or my spouse's name | 16,000 | $60.73 | $971,680.00 |
DisclosureSEC source: 0001437749-21-006361 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 11, 2021, the Compensation Committee amended the option to grant the ability to exercise up to 100% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original vest date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name or my spouse's name | 510 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004202 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,285 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2022, the next 33 1/3% vesting on 1/1/2023, and the final 33 1/3% vesting on 1/1/2024. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $60.73 | $0.00 |
DisclosureSEC source: 0001437749-21-000417 · rdgdoc.xml · derivative · entry 4 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 24,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 13, 2020, the Compensation Committee amended the option to grant the right to exercise up to 25% of the option on or before March 9, 2022 (using up to three separate exercise dates). Any shares issued upon exercise are to be held as restricted stock until February 9, 2022, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 13, 2020, the Compensation Committee amended the option to grant the right to exercise up to 25% of the option on or before March 9, 2022 (using up to three separate exercise dates). Any shares issued upon exercise are to be held as restricted stock until February 9, 2022, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name or my spouse's name | 6,905 | $73.97 | $510,762.85 |
DisclosureSEC source: 0001437749-21-000417 · rdgdoc.xml · nonDerivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,775 F3 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F4 · balance_after: Total amount of common shares owned following transactions reported on this form. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name or my spouse's name | 8,000 | $60.73 | $485,840.00 |
DisclosureSEC source: 0001437749-21-000417 · rdgdoc.xml · nonDerivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 13, 2020, the Compensation Committee amended the option to grant the right to exercise up to 25% of the option on or before March 9, 2022 (using up to three separate exercise dates). Any shares issued upon exercise are to be held as restricted stock until February 9, 2022, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 01, 2021 Filed Jan 8, 2021 21:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name or my spouse's name | 122 | $66.41 | $8,102.02 |
DisclosureSEC source: 0001437749-21-000417 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,680 F1 · shares: On 1/1/2021, 33 1/3 (or 414 shares) of restricted stock originally granted on 2/22/2019 and 2/21/2020 vested. The Company withheld 122 to pay tax obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:27 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name or my spouse's name | 563 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003523 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,802 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2021, 66 2/3% on 1/1/2022, and 100% on 1/1/2023. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 22:58 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock held in my name or my spouse's name | 678 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-003299 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,239 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2020, 66 2/3% on 1/1/2021, and 100% on 1/1/2022. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:08 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 8,000 | $0.00 Strike: $60.73 | $0.00 |
DisclosureSEC source: 0001437749-19-003097 · rdgdoc.xml · derivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 32,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 25% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 25% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:08 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock held in my name or my spouse's name | 6,439 | $84.03 | $541,069.17 |
DisclosureSEC source: 0001437749-19-003097 · rdgdoc.xml · nonDerivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,561 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of common shares owned following transactions reported on this form. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:08 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock held in my name or my spouse's name | 8,000 | $60.73 | $485,840.00 |
DisclosureSEC source: 0001437749-19-003097 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. On February 14, 2019, the Compensation Committee amended the option to grant a 30 day window to exercise up to 25% of this option, with any shares issued upon exercise to be held as restricted stock until 2/9/22, the original date exercisable. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 14, 2018 Filed Jun 20, 2018 14:19 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 32,000 | $0.00 Strike: $60.73 | $0.00 |
DisclosureSEC source: 0001437749-18-012114 · rdgdoc.xml · derivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2022-03-11 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on March 14, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.